Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration A Phase 3 Randomized Clinical Trial

Woo Se Joon and Bradvica Mario and Vajas Attila and Sagong Min and Ernest Jan and Studnicka Jan and Veith Miroslav and Wylegala Edward and Patel Sunil and Yun Cheolmin and Orski Michal and Astakhov Sergei and Tóth-Molnár Edit and Csutak Adrienne and et al.: Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration A Phase 3 Randomized Clinical Trial.
JAMA OPHTHALMOLOGY, 141 (7). pp. 668-676. ISSN 2168-6165 (2023)

[thumbnail of 34015428_megjelent.pdf] Text
34015428_megjelent.pdf - Published Version

Download (366kB)
[thumbnail of jamaophthalmology_woo_2023_oi_230029_1686145167.12501.pdf] Text
jamaophthalmology_woo_2023_oi_230029_1686145167.12501.pdf - Accepted Version

Download (366kB)
Item Type: Journal Article
Szerzők száma: 19
Journal or Publication Title: JAMA OPHTHALMOLOGY
Date: 2023
Volume: 141
Number: 7
Page Range: pp. 668-676
ISSN: 2168-6165
Faculty/Unit: Albert Szent-Györgyi Medical School
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 34015428
DOI azonosító: https://doi.org/10.1001/jamaophthalmol.2023.2260
Date Deposited: 2023. Jun. 15. 08:41
Last Modified: 2023. Jul. 28. 10:46
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/27429
Web of Science® Times Cited: 4 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year